Abstract
Cardiovascular disease is the leading cause of death of women in the United States, yet cardiovascular research is disproportionately conducted using male human subjects and male animal models. This article deploys Katrina Hutchison’s (2019) analysis of gender disparity in clinical trials as a moral aggregation problem to address the problem of underrepresentation of women in cardiovascular research. I identify cost concerns, convenience, pregnancy, and negligence as potential reasons for the underrepresentation of women in CVD research. Finally, I suggest that multilevel strategies will be needed to eliminate sex disparity in CVD research and improve patient care.
Publisher
University of Toronto Press Inc. (UTPress)
Subject
Philosophy,Health (social science),Gender Studies
Reference44 articles.
1. American Heart Association (AHA). 2020. “Changing the Way We View Women’s Heart Attack Symptoms.” Heart.org, March 6. https://www.heart.org/en/news/ 2020/03/06/changing-the-way-we-view-womens-heart-attack-symptoms
2. Barlow, Rich. 2014. “Why Medical Research Often Ignores Women.” BU Today, March 28. http://www.bu.edu/today/2014/why-medical-research-often-ignores-women/
3. Wanted: Inclusive Guidelines for Research Involving Pregnant Women
4. Enrolling Pregnant Women: Issues in Clinical Research